| 12.10 Delayed Data As of Aug 23 |  -0.41 / -3.28%Today’s Change | 11.70 Today|||52-Week Range 29.97 | -27.33% Year-to-Date |
| Previous close | 12.51 |
| Today’s open | 12.54 |
| Day’s range | 12.05 - 12.60 |
| Volume | 97,538 |
| Average volume (3 months) | 110,952 |
| Market cap | $522.1M |
| Earnings growth (last year) | +31.22% |
| Earnings growth (this year) | -38.63% |
| Earnings growth (next 5 years) | +1.50% |
| Revenue growth (last year) | -49.92% |
| P/E ratio | NM |
| Price/Sales | 53.38 |
| Price/Book | 1.27 |
| Today’s change | Today’s % change | |
|---|---|---|
| KNSAKiniksa Pharmaceutic... | -0.99 | -10.04% |
| AKBAAkebia Therapeutics ... | -0.21 | -4.93% |
| VKTXViking Therapeutics ... | -0.33 | -4.71% |
| KPTIKaryopharm Therapeut... | -0.46 | -5.02% |
| Next reporting date | November 19, 2019 |
| EPS forecast (this quarter) | -$0.81 |
| Annual revenue (last year) | $12.7M |
| Annual profit (last year) | -$78.6M |
| Net profit margin | -618.12% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer André Choulika |
Chief Operating Officer Elsy Boglioli |
Corporate headquarters Paris, Ile-de-france |
